210 related articles for article (PubMed ID: 24261474)
1. Correlations between prescription opioid analgesic dispensing levels and related mortality and morbidity in Ontario, Canada, 2005-2011.
Fischer B; Jones W; Urbanoski K; Skinner R; Rehm J
Drug Alcohol Rev; 2014 Jan; 33(1):19-26. PubMed ID: 24261474
[TBL] [Abstract][Full Text] [Related]
2. High correlations between levels of consumption and mortality related to strong prescription opioid analgesics in British Columbia and Ontario, 2005-2009.
Fischer B; Jones W; Rehm J
Pharmacoepidemiol Drug Saf; 2013 Apr; 22(4):438-42. PubMed ID: 23319301
[TBL] [Abstract][Full Text] [Related]
3. Correlations between population-levels of prescription opioid dispensing and related deaths in Ontario (Canada), 2005-2016.
Fischer B; Jones W; Varatharajan T; Malta M; Kurdyak P
Prev Med; 2018 Nov; 116():112-118. PubMed ID: 30217407
[TBL] [Abstract][Full Text] [Related]
4. Trends and changes in prescription opioid analgesic dispensing in Canada 2005-2012: an update with a focus on recent interventions.
Fischer B; Jones W; Rehm J
BMC Health Serv Res; 2014 Feb; 14():90. PubMed ID: 24572005
[TBL] [Abstract][Full Text] [Related]
5. Prescription Opioid Use, Harms and Interventions in Canada: A Review Update of New Developments and Findings since 2010.
Murphy Y; Goldner EM; Fischer B
Pain Physician; 2015; 18(4):E605-14. PubMed ID: 26218951
[TBL] [Abstract][Full Text] [Related]
6. Use and nonmedical use of prescription opioid analgesics in the general population of Canada and correlations with dispensing levels in 2009.
Shield KD; Jones W; Rehm J; Fischer B
Pain Res Manag; 2013; 18(2):69-74. PubMed ID: 23662288
[TBL] [Abstract][Full Text] [Related]
7. Harms of prescription opioid use in the United States.
Imtiaz S; Shield KD; Fischer B; Rehm J
Subst Abuse Treat Prev Policy; 2014 Oct; 9():43. PubMed ID: 25352167
[TBL] [Abstract][Full Text] [Related]
8. Changes in and characteristics of admissions to treatment related to problematic prescription opioid use in Ontario, 2004-2009.
Fischer B; Nakamura N; Rush B; Rehm J; Urbanoski K
Drug Alcohol Depend; 2010 Jun; 109(1-3):257-60. PubMed ID: 20197216
[TBL] [Abstract][Full Text] [Related]
9. Geographic Variations in Prescription Opioid Dispensations and Deaths Among Women and Men in British Columbia, Canada.
Gladstone EJ; Smolina K; Weymann D; Rutherford K; Morgan SG
Med Care; 2015 Nov; 53(11):954-9. PubMed ID: 26465123
[TBL] [Abstract][Full Text] [Related]
10. Evaluating the population-level effects of oxycodone restrictions on prescription opioid utilization in Ontario.
Rudoler D; Kurdyak P; Gomes T; Huang A; Jones W; Littleford S; Paracha N; Fischer B
Pharmacoepidemiol Drug Saf; 2022 Jul; 31(7):769-778. PubMed ID: 35470515
[TBL] [Abstract][Full Text] [Related]
11. Correlations between opioid mortality increases related to illicit/synthetic opioids and reductions of medical opioid dispensing - exploratory analyses from Canada.
Fischer B; Jones W; Tyndall M; Kurdyak P
BMC Public Health; 2020 Jan; 20(1):143. PubMed ID: 32005211
[TBL] [Abstract][Full Text] [Related]
12. Patterns, Changes, and Trends in Prescription Opioid Dispensing in Canada, 2005-2016.
Fischer B; Jones W; Vojtila L; Kurdyak P
Pain Physician; 2018 May; 21(3):219-228. PubMed ID: 29871366
[TBL] [Abstract][Full Text] [Related]
13. Examining correlations between opioid dispensing and opioid-related hospitalizations in Canada, 2007-2016.
Jones W; Kurdyak P; Fischer B
BMC Health Serv Res; 2020 Jul; 20(1):677. PubMed ID: 32698815
[TBL] [Abstract][Full Text] [Related]
14. Differences and over-time changes in levels of prescription opioid analgesic dispensing from retail pharmacies in Canada, 2005-2010.
Fischer B; Jones W; Krahn M; Rehm J
Pharmacoepidemiol Drug Saf; 2011 Dec; 20(12):1269-77. PubMed ID: 21755568
[TBL] [Abstract][Full Text] [Related]
15. Non-medical use of prescription opioids and prescription opioid-related harms: why so markedly higher in North America compared to the rest of the world?
Fischer B; Keates A; Bühringer G; Reimer J; Rehm J
Addiction; 2014 Feb; 109(2):177-81. PubMed ID: 23692335
[TBL] [Abstract][Full Text] [Related]
16. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P
Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626
[TBL] [Abstract][Full Text] [Related]
17. Prescription opioid related misuse, harms, diversion and interventions in Canada: a review.
Fischer B; Argento E
Pain Physician; 2012 Jul; 15(3 Suppl):ES191-203. PubMed ID: 22786457
[TBL] [Abstract][Full Text] [Related]
18. Pharmaceutical opioid analgesic and heroin dependence: how do treatment-seeking clients differ in Australia?
Nielsen S; Bruno R; Lintzeris N; Fischer J; Carruthers S; Stoové M
Drug Alcohol Rev; 2011 May; 30(3):291-9. PubMed ID: 21545560
[TBL] [Abstract][Full Text] [Related]
19. Cohort Study of the Impact of High-Dose Opioid Analgesics on Overdose Mortality.
Dasgupta N; Funk MJ; Proescholdbell S; Hirsch A; Ribisl KM; Marshall S
Pain Med; 2016 Jan; 17(1):85-98. PubMed ID: 26333030
[TBL] [Abstract][Full Text] [Related]
20. Rates of opioid dispensing and overdose after introduction of abuse-deterrent extended-release oxycodone and withdrawal of propoxyphene.
Larochelle MR; Zhang F; Ross-Degnan D; Wharam JF
JAMA Intern Med; 2015 Jun; 175(6):978-87. PubMed ID: 25895077
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]